Use in pregnancy: Animal reproduction studies have not been conducted with Mycostatin oral suspension. It is also not known whether Mycostatin oral suspension can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Mycostatin oral suspension should be prescribed to pregnant women only if the potential benefit to the mother outweighs the potential risk to the fetus.
Use in lactation: It is not known whether nystatin is excreted in human milk. Though gastrointestinal absorption is insignificant, caution should be exercised when nystatin is prescribed to nursing women.